Asthme sévère : mission Rémission
- 7 July 2023
- journal article
- research article
- Published by Elsevier in Revue des Maladies Respiratoires Actualités
- Vol. 15 (1) , 1S12-1S16
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- A randomized multicenter study evaluating Xolair persistence of response after long-term therapyJournal of Allergy and Clinical Immunology, 2017
- Patterns of Growth and Decline in Lung Function in Persistent Childhood AsthmaNew England Journal of Medicine, 2016
- Limited treatment adaptation despite poor asthma control in asthma patients treated with inhaled corticosteroidsJournal of Asthma, 2015
- A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patientsJournal of Allergy and Clinical Immunology, 2013
- Dupilumab in Persistent Asthma with Elevated Eosinophil LevelsNew England Journal of Medicine, 2013
- Local and systemic immunological parameters associated with remission of asthma symptoms in childrenAllergy, Asthma & Clinical Immunology, 2012
- Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLARAllergy, 2004
- The Melbourne Asthma Study: 1964-1999Journal of Allergy and Clinical Immunology, 2002
- Airway Inflammation Is Present during Clinical Remission of Atopic AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmaticsEuropean Respiratory Journal, 2001